Cardiovascular Surgery Devices And Equipment Market 2024-2033 | Size, Trends, Insights, Demand, Outlook

The cardiovascular surgery devices and equipment market size has grown steadily in recent years. It will grow from $1.79 billion in 2023 to $1.87 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to prevalence of cardiovascular diseases, technological advancements, aging population, chronic disease management.

The cardiovascular surgery devices and equipment market size is expected to see steady growth in the next few years. It will grow to $2.16 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to minimally invasive surgery, advanced imaging, personalized medicine, telemedicine and teleconsultations. Major trends in the forecast period include hybrid operating rooms, transcatheter procedures, artificial intelligence (ai) in surgery, remote surgical training.

Market Overview -
Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system and damaged or blocked valves and vessels.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp

Growing Geriatric Population And Cardiovascular Mortality Rates Propel The Cardiovascular Surgical Devices Market
The rising geriatric population along with the rising deaths related to cardiovascular disorders is driving the cardiovascular surgical devices market. According to American Heart Association (AHA), in the US, approximately 43.7 million aged above 60 suffered from cardiovascular disorders. It is also reported by AHA that death related to cardiac diseases amount to 17.3 million per year and is expected to rise to more than 23.6 million by 2030, worldwide. Due to these factors, a higher number of surgeries are being performed, thereby driving the market.

Competitive Landscape -
Major companies operating in the cardiovascular surgery devices and equipment market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton Dickinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A.

Innovations In Second-Generation Bioresorbable Stents Fuel Growth In The Cardiovascular Surgery Devices Market
Companies in the cardiovascular surgery devices and equipment market are investing in second-generation bioresorbable stents and as well rectifying the glitches which occurred in the earlier version of bioresorbable stents. This advancing segment is poised to garner $247 million by 2025. Due to the all-new device features such as thinner strut thicknesses, faster resorption times, and better radial force, these are expected to grow at a higher growth rate. A higher elective procedure volume due to the less-invasive nature of PCIs, when compared to coronary artery bypass grafting, is expected to drive bioresorbable stents adoption. For instance, Amaranth Medical has developed three medical devices with thinner strut thickness, the latest bearing a magnitude of 100 microns.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Key Segments -

The cardiovascular surgery devices and equipment market covered in this report is segmented -

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.